Phenotype Switching Is a Natural Consequence of Staphylococcus aureus Replication
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The pathogen Staphylococcus aureus undergoes phenotype switching in vivo from its normal colony phenotype (NCP) to a slow-growing, antibiotic-resistant small-colony-variant (SCV) phenotype that is associated with persistence in host cells and tissues. However, it is not clear whether phenotype switching is the result of a constitutive process that is selected for under certain conditions or is triggered by particular environmental stimuli. Examination of cultures of diverse S. aureus strains in the absence of selective pressure consistently revealed a small gentamicin-resistant SCV subpopulation that emerged during exponential-phase NCP growth and increased in number until NCP stationary phase. Treatment of replicating bacteria with the antibiotic gentamicin, which inhibited NCP but not SCV replication, resulted in an initial decrease in SCV numbers, demonstrating that SCVs arise as a consequence of NCP replication. However, SCV population expansion in the presence of gentamicin was reestablished by selection of phenotype-stable SCVs and subsequent SCV replication. In the absence of selective pressure, however, phenotype switching was bidirectional and occurred at a high frequency during NCP replication, resulting in SCV turnover. In summary, these data demonstrate that S. aureus phenotype switching occurs via a constitutive mechanism that generates a dynamic, antibiotic-resistant subpopulation of bacteria that can revert to the parental phenotype. The emergence of SCVs can therefore be considered a normal part of the S. aureus life cycle and provides an insurance policy against exposure to antibiotics that would otherwise eliminate the entire population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, SCVs that appeared in the cultures were generated by the acquisition of mutations in wild-type cells (22).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we used a previously described stability assay (22) and found that SCVs that arose in cultures exposed to H2O2 or paraquat were significantly more stable than those that arose in broth only (Fig. 4C, D, and E).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [22]
In the citing paper
“Previous work has shown that gentamicin-resistant SCVs emerge in replicating populations in the absence of environmental stress via stochastic mutations but frequently revert to the wild type (WT) via the acquisition of suppressor mutations (15, 17, 22).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [22]
In the citing paper
“As reported previously, wild-type S. aureus grew rapidly in the absence of H2O2 and produced a small SCV subpopulation during the early exponential phase (Fig. 2A) (22).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [22]
In the citing paper
“Previous work has shown that the tetracycline-resistant strain does not suffer a fitness cost under the conditions used (22).”
From Staphylococcus aureus Adapts to Oxidative Stress by Producing H 2 O 2 -Resistant Small-Colony Variants via the SOS Response (2015) · cites this paper as [22]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Bacterial Persistence as a Phenotypic Switch
Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L., & Leibler, S. (2004) · Science · doi:10.1126/science.1099390 · Cited by 2,952 · cited 3×
“Phenotype switching from a normal to a slow-growing or dormant phenotype is a widely employed bet-hedging strategy to insure bacteria against environmental conditions that might otherwise eradicate the entire population (3, 17, 19, 37).”
BackgroundPersister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 3×
“Phenotype switching from a normal to a slow-growing or dormant phenotype is a widely employed bet-hedging strategy to insure bacteria against environmental conditions that might otherwise eradicate the entire population (3, 17, 19, 37).”
BackgroundProctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Staphylococcus aureus biofilms: Properties, regulation, and roles in human disease
Archer, N. K., Mazaitis, M. J., Costerton, J. W., Leid, J. G., Powers, M. E., & Shirtliff, M. E. (2011) · Virulence · doi:10.4161/viru.2.5.17724 · Cited by 1,018
Horsburgh, M. J., Aish, J. L., White, I. J., Shaw, L., Lithgow, J. K., & Foster, S. J. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.19.5457-5467.2002 · Cited by 699
Mutation as a Stress Response and the Regulation of Evolvability
Galhardo, R. S., Hastings, P. J., & Rosenberg, S. M. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701648502 · Cited by 643 · cited 1×
“While it may seem reasonable to expect mutations to occur during replication, there is convincing evidence that mutation rates increase in stationary phase compared with exponential phase (10, 20, 26, 29).”
BackgroundKussell, E., Kishony, R., Balaban, N. Q., & Leibler, S. (2005) · Genetics · doi:10.1534/genetics.104.035352 · Cited by 584
Staphylococcus aureus: new evidence for intracellular persistence
Garzoni, C., & Kelley, W. L. (2009) · Trends in Microbiology · doi:10.1016/j.tim.2008.11.005 · Cited by 474 · cited 1×
“aureus persists within host tissues are poorly understood but likely include both biofilm formation and intracellular residency, both of which confer a degree of protection against immune components and antimicrobial therapy (1, 9, 11, 23, 28).”
BackgroundPersistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437 · cited 4×
“Such auxotrophic phenotypes have been reported previously in clinical samples (5, 13, 15, 30, 31).”
BackgroundInfluential
Cited by
Kahl, B. C., Becker, K., & Löffler, B. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00069-15 · Cited by 325
“Although SCVs have been described to occur during the normal growth cycle in in vitro studies (28), their occurrence during acute S.”
BackgroundProctor, R. A., Kriegeskorte, A., Kahl, B. C., Becker, K., Löffler, B., & Peters, G. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00099 · Cited by 237
“A subset of organisms within many bacterial populations can be part of the normal growth cycle (Lechner et al., 2012), and this is certainly true for S. aureus SCVs, which are part of the normal growth cycle that occurs without any external stresses (Massey et al., 2001; Edwards, 2012).”
BackgroundCollective antibiotic resistance: mechanisms and implications
Vega, N. M., & Gore, J. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.09.003 · Cited by 192
Garcia, L. G., Lemaire, S., Kahl, B. C., Becker, K., Proctor, R. A., Denis, O., Tulkens, P. M., & Van Bambeke, F. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt072 · Cited by 177
Vulin, C., Leimer, N., Huemer, M., Ackermann, M., & Zinkernagel, A. S. (2018) · Nature Communications · doi:10.1038/s41467-018-06527-0 · Cited by 167
Tuchscherr, L., Löffler, B., & Proctor, R. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01028 · Cited by 143
“Furthermore, clinical SCV isolates are often unstable and revert to their wild-type phenotype when cultured in rich bacterial growth medium (Kahl et al., 2005; Proctor et al., 2006; Edwards, 2012).”
BackgroundPainter, K. L., Strange, E., Parkhill, J., Bamford, K. B., Armstrong-James, D., & Edwards, A. M. (2015) · Infection and Immunity · doi:10.1128/iai.03016-14 · Cited by 153
“(C, D, and E) The relative stability of SCVs isolated from cultures without (TSB) (C) or with H2O2 (D) or paraquat (para) (E) were determined by using a previously described assay (22).”
BackgroundMethodInfluentialSelf-citationGuo, H., Tong, Y., Cheng, J., Abbas, Z., Li, Z., Wang, J., Zhou, Y., Si, D., & Zhang, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031241 · Cited by 120
“Phenotypic change is a part of the normal growth cycle of the bacteria [8], and acts as an insurance approach to avoid harmful environments [9].”
BackgroundNeutrophil-generated oxidative stress and protein damage in Staphylococcus aureus
Beavers, W. N., & Skaar, E. P. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw060 · Cited by 143
Tuchscherr, L. P. N., Kreis, C., Hoerr, V., Flint, L., Hachmeister, M., Geraci, J., Bremer-Streck, S., Kiehntopf, M., Medina, E., Kribus, M., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv371 · Cited by 130
Growth and Laboratory Maintenance of Staphylococcus aureus
Missiakas, D. M., & Schneewind, O. (2013) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc09c01s28 · Cited by 156
“SCVs are defective in electron transport and can be isolated from persistent infections in humans and following infection of tissue cultures (Proctor et al., 1998) or when bacteria are grown under antibiotic stress conditions in vitro (Edwards, 2012).”
BackgroundSmall colony variants (SCVs) of Staphylococcus aureus – A bacterial survival strategy
Kahl, B. C. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.05.016 · Cited by 118
“Phenotypic switching including the emergence of SCVs represent a part of the normal growth cycle (Edwards, 2012; Swingle, 1935) as an insurance policy (Boles et al.”
BackgroundHommes, J. W., & Surewaard, B. G. J. (2022) · Biomedicines · doi:10.3390/biomedicines10081804 · Cited by 97
A comprehensive review of bacterial osteomyelitis with emphasis on Staphylococcus aureus
Nasser, A., Azimi, T., Ostadmohammadi, S., & Ostadmohammadi, S. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104431 · Cited by 90
Evasion of host defenses by intracellular Staphylococcus aureus
Watkins, K. E., & Unnikrishnan, M. (2020) · Advances in applied microbiology · doi:10.1016/bs.aambs.2020.05.001 · Cited by 93
Aminoglycoside Heteroresistance in Acinetobacter baumannii AB5075
Anderson, S. E., Sherman, E. X., Weiss, D. S., & Rather, P. N. (2018) · mSphere · doi:10.1128/msphere.00271-18 · Cited by 75
Berditsch, M., Afonin, S., Reuster, J., Lux, H., Schkolin, K., Babii, O., Radchenko, D. S., Abdullah, I., William, N., Middel, V., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-54212-z · Cited by 63
Evolution of Staphylococcus aureus during human colonization and infection
Fitzgerald, J. R. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.04.020 · Cited by 59
Unexpected synergistic and antagonistic antibiotic activity against Staphylococcus biofilms
Dall, G. F., Tsang, S. J., Gwynne, P. J., Mackenzie, S. P., Simpson, H., Breusch, S. J., & Gallagher, M. P. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky087 · Cited by 63
Lacoma, A., Edwards, A. M., Young, B., Domínguez, J., Prat, C., & Laabei, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-47258-6 · Cited by 60
Self-citationLee, J., Zilm, P. S., & Kidd, S. P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00321 · Cited by 51
“Clinically isolated SCVs are often not stable and revert to their non-SCV cell type when cultured in the laboratory (Edwards, 2012; Kriegeskorte et al., 2014a; Bui et al., 2015).”
BackgroundMarquès, C., Tasse, J., Pracros, A., Collin, V., Franceschi, C., Laurent, F. J., Chatellier, S., & Forestier, C. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000125 · Cited by 46
Staphylococcus aureus (Including Staphylococcal Toxic Shock Syndrome)
Que, Y., & Moreillon, P. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00196-x · Cited by 54
Painter, K. L., Hall, A., Ha, K. P., & Edwards, A. M. (2017) · Infection and Immunity · doi:10.1128/iai.00659-17 · Cited by 51
“repair of the causative mutation or acquisition of a suppressor mutation (18, 19, 22).”
BackgroundSelf-citationTan, N. C.-W., Cooksley, C. M., Roscioli, E., Drilling, A., Douglas, R. G., Wormald, P. J., & Vreugde, S. (2014) · Allergy · doi:10.1111/all.12457 · Cited by 43
“One factor that has been described as a potential mechanism is known as the ‘bet-hedging strategy’ (30).”
BackgroundHost-directed kinase inhibitors act as novel therapies against intracellular Staphylococcus aureus
Bravo-Santano, N., Stölting, H., Cooper, F., Bileckaja, N., Majstorović, A., Ihle, N., Mateos, L. M., Calle, Y., Behrends, V., & Letek, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-41260-8 · Cited by 44
Frenzel, E., Kranzler, M., Stark, T. D., Hofmann, T. F., & Ehling‐Schulz, M. (2015) · mBio · doi:10.1128/mbio.01172-15 · Cited by 41
“Azithromycin S (22) S (21) S (22) S (24) S (23) S (23) S (25) S (24) Cefepime R (10) R (11) R (9) S (22) S (19) S (23) S (22) S (21) Chloramphenicol S (27) S (27) S (27) S (28) S (26) S (28) S (29) S (27) Ciprofloxacin S (26) S (26) S (28) S (29) S (28) S (29) S (31) S (32) Clindamycin S (22) S (21) S (22) S (20) S (2…”
BackgroundPacocha, N., Bogusławski, J., Horka, M., Makuch, K., Liżewski, K., Wojtkowski, M., & Garstecki, P. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c03408 · Cited by 38
Diverse molecular mechanisms underpinning Staphylococcus aureus small colony variants
Mapar, M., Rydzak, T., Hommes, J. W., Surewaard, B. G. J., & Lewis, I. A. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.09.007 · Cited by 34
Activation of the SOS response increases the frequency of small colony variants
Vestergaard, M. R., Paulander, W., & Ingmer, H. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1735-2 · Cited by 36
“aureus population a sub-population exists as SCVs [10], however environmental stimuli may increase the frequency of SCV formation.”
BackgroundPader, V., James, E. H., Painter, K. L., Wigneshweraraj, S., & Edwards, A. M. (2014) · Infection and Immunity · doi:10.1128/iai.02254-14 · Cited by 32
Self-citationP. aeruginosa interactions with other microbes in biofilms during co-infection
Oliveira, M., Cunha, E. S., Tavares, L. M., & Serrano, I. D. (2023) · AIMS Microbiology · doi:10.3934/microbiol.2023032 · Cited by 33
“aureus SCV, they exhibit an intrinsic tolerance to antibiotics, which is not necessarily associated with antimicrobial resistance genes [206].”
BackgroundBogut, A., & Magryś, A. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04315-1 · Cited by 30
Zhang, P., Wright, J. A., Osman, A. A., & Nair, S. P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01001 · Cited by 31
“This is also consistent with the findings reported by Edwards (2012) that the formation of SCVs from NCP cells is a natural process during replication rather than a consequence of selective pressure, and that SCV-NCP switching occurs spontaneously during bacterial replication in the absence of…”
InfluentialBravo-Santano, N., Ellis, J., Calle, Y., Keun, H., Behrends, V., & Letek, M. (2019) · Metabolites · doi:10.3390/metabo9070148 · Cited by 25
“aureus USA300 LAC strain [49] was cultured in Nutrient Broth (NB) medium (Sigma-Aldrich, Gillingham, UK).”
MethodLenhard, J. R., von Eiff, C., Hong, I. S., Holden, P. N., Bear, M. D., Suen, A., Bulman, Z. P., & Tsuji, B. T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04508-14 · Cited by 29
“aureus SCV cells exist in a dynamic equilibrium with cells of the NP, and the emergence of SCVs in persistent infections is attributed to the survival advantage of preexisting SCVs compared to the survival of strains with the NP during vancomycin exposure (15, 16).”
BackgroundDenture stomatitis associated with small-colony variants of Staphylococcus aureus: a case report
Garbacz, K., Kwapisz, E., & Wierzbowska, M. (2019) · BMC Oral Health · doi:10.1186/s12903-019-0910-6 · Cited by 28
Curtis, T. D., Gram, L., & Knudsen, G. M. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01056 · Cited by 26
“These variants can either be fixed, which is the result of a mutation in one of the biosynthesis or metabolism genes for the aforementioned compounds, or transient, alternating between the wild type and SCV phenotypes during replication (Edwards, 2012).”
BackgroundSmall-Colony Variants in Persistent and Recurrent Staphylococcus aureus Bacteremia
Kim, K.-H., Kang, Y. M., Han, W. D., Park, K. U., Park, K., Yoo, J. I., Lee, D., Park, C., Song, K., Kim, E. S., et al. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0262 · Cited by 28
“39 Likewise, many clinical SCV isolates were reported to be phenotypically unstable, reverting to a normal appearance when grown under laboratory conditions.”
Auraß, P., Düvel, J., Karste, S., Nübel, U., Rabsch, W., & Flieger, A. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.01838-17 · Cited by 21
“populations, as shown for Staphylococcus aureus (11).”
Christmas, B. A. F., Rolfe, M. D., Rose, M. W., & Green, J. D. (2019) · Microbiology · doi:10.1099/mic.0.000809 · Cited by 21
Alves, J., Vrieling, M., Ring, N., Yebra, G., Pickering, A. C., Prajsnar, T. K., Renshaw, S. A., & Fitzgerald, J. R. (2024) · mBio · doi:10.1128/mbio.00346-24 · Cited by 20
“Importantly, SCV pheno types are often dynamic and many can revert to fully virulent wild-type forms in the extracellular milieu (28).”
BackgroundLiu, J., Zhang, J., Guo, L., Zhao, W., Hu, X., & Wei, X. (2017) · Biofouling · doi:10.1080/08927014.2017.1323206 · Cited by 21
Cryptic resistance in Staphylococcus aureus: a risk for the treatment of skin infection?
Saeed, K. B. A., Marsh, P., & Ahmad, N. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000046 · Cited by 22
Giuliano, S., Angelini, J., D’Elia, D., Geminiani, M., Barison, R. D., Giacinta, A., Sartor, A., Campanile, F., Curcio, F., Cotta, M. O., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12050879 · Cited by 19
“, antibiotic-resistant morphologic variants that grow into tiny colonies [57] and are the results of the intrinsic bacterial ability to survive anti-infective drugs) [58].”
BackgroundBravo-Santano, N., Capilla‐Lasheras, P., Mateos, L. M., Calle, Y., Behrends, V., & Letek, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-51894-3 · Cited by 18
Wang, X., Li, W., Wang, W., Wang, S., Xu, T., Chen, J., & Zhang, W. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.756809 · Cited by 17
Schleimer, N., Kaspar, U., Drescher, M., Seggewiß, J., von Eiff, C., Proctor, R. A., Peters, G., Kriegeskorte, A., & Becker, K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01863 · Cited by 17
“…to adapt to an intracellular lifestyle protecting them against the host defense system and antimicrobial therapy resulting in persistent, relapsing, and often therapy-refractory chronic infections (Tuchscherr et al., 2010, 2011; Kriegeskorte et al., 2011, 2014b; Edwards, 2012; Kahl et al., 2016).”
BackgroundMicrocolonies: a novel morphological form of pathogenic Mycoplasma spp.
Rakovskaya, I. V., Ermolaeva, S. A., Levina, G. A., Barkhatova, O. I., Mukhachev, A. Y., Andreevskaya, S. G., Zhukhovitsky, V. G., Gorina, L. G., Miller, G. G., & Sysolyatina, E. V. (2019) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001081 · Cited by 17
Stoneham, S. M., Cantillon, D. M., Waddell, S. J., & Llewelyn, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01300 · Cited by 15
“…to increase the proportion of the population exhibiting a non-stable SCV phenotype through exposure to antibiotics, particularly aminoglycosides (Edwards, 2012; Vestergaard et al., 2016) and trimethoprim (Kahl et al., 1998), and to conditions mimicking the intracellular environment, including…”
BackgroundMethodResultInfluentialSubpopulations in Strains of Staphylococcus aureus Provide Antibiotic Tolerance
Mashayamombe, M., Carda‐Diéguez, M., Mira, Á., Fitridge, R., Zilm, P. S., & Kidd, S. P. (2023) · Antibiotics · doi:10.3390/antibiotics12020406 · Cited by 13
“aureus, with a dynamic, antibiotic-tolerant subpopulation (the SCVs) being generated during cell replication (alongside the active cells), and these can rapidly revert to the parental type in the absence of a selective pressure [25].”
BackgroundNurjadi, D., Chanthalangsy, Q., Zizmann, E., Stuermer, V., Moll, M., Klein, S., Boutin, S., Heeg, K., & Zanger, P. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01510-21 · Cited by 10
“aureus during replication (23), so that the observed heteroresistance can be the result of a spontaneous phenotypic switch or the emergence of a hemin-auxotrophic subpopulation.”
BackgroundAnin vitroandex vivowound infection model to test topical and systemic treatment with antibiotics
Cheng, Y., Bank, P. D., & Bolhuis, A. (2022) · Journal of Applied Microbiology · doi:10.1111/jam.15756 · Cited by 10
“SCVs are a slow- growing subpopulation of bacteria that are selected for by gentamicin (Edwards, 2012), as they are more resistant because of a deficiency in gentamicin uptake (Miller et al.”
BackgroundInfluentialFunctional mgrA Influences Genetic Changes within a Staphylococcus aureus Cell Population over Time
Lee, J. D., Carda‐Diéguez, M., Žiemytė, M., Vreugde, S., Cooksley, C. M., Crosby, H. A., Horswill, A. R., Mira, Á., Zilm, P. S., & Kidd, S. P. (2022) · Journal of Bacteriology · doi:10.1128/jb.00138-22 · Cited by 9
“aureus populations during normal growth in the absence of any selective pressures (5), but only being detectable when there are conditions which favor their survival while being non-permissive to the active cell types.”
BackgroundThe crafty opponent: the defense systems of Staphylococcus aureus and response measures
Hou, H., Yang, L., Jin, Y., Chen, S., Long, J., Duan, G., & Yang, H. (2022) · Folia Microbiologica · doi:10.1007/s12223-022-00954-9 · Cited by 8
Pacocha, N., Zapotoczna, M., Makuch, K., Bogusławski, J., & Garstecki, P. (2022) · Lab on a Chip · doi:10.1039/d2lc00234e · Cited by 8
Fe-S cluster deficiency drives small colony variant formation in persistent infections
Chen, T., Ye, Z., Huang, W., Zhang, Q., Jiang, F., Yang, Z., Jian, Y., Wang, Y., Xiang, G., Liu, Q., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.018 · Cited by 6
“Unstable SCVs, arising from transient stressors (e.g., subin-hibitory antibiotics or nutrient deprivation) [8], frequently revert to wild-type phenotypes upon subculture in nutrient-rich media [9,10].”
Kreis, C., Aschenbrenner, F. K., Guenther, D., Tholema-Hans, N., Köppe, J., Roßlenbroich, S. B., Raschke, M. J., & Fuchs, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-07673-8 · Cited by 9
Cheng, X., Shi, Y., Liu, Y., Xu, Y., Ma, J., Ma, L., Wang, Z., Guo, S., & Su, J. (2024) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-024-04128-2 · Cited by 6
“These characteristics are more precisely identified as small colony variants (SCV), believed to be a natural component of the S. aureus lifecycle, enabling the population to persist in the presence of antibiotics (Edwards 2012).”
Pulkkinen, K., Ketola, T., Laakso, J. T., Mappes, J., & Sundberg, L. (2022) · Evolutionary Applications · doi:10.1111/eva.13355 · Cited by 6
“In clonally replicating bacteria, the heterogeneity of the phenotype can be achieved by stochastic switching between alternative phenotypes produced by the same genotype (Balaban et al., 2004; Veening et al., 2008; Edwards, 2012; Ackermann, 2015; D’Souza, 2020).”
BackgroundBogut, A., Koper, P., Marczak, M., & Całka, P. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1289844 · Cited by 6
“The study of Edwards (Edwards, 2012) demonstrated that this transition occurs via a constitutive mechanism depending upon bacterial replication.”
BackgroundAntimicrobial Resistance and Virulence Common Mechanisms
Giraud, É., Rychlík, I., & Cloeckaert, A. (2017) · Frontiers research topics · doi:10.3389/978-2-88945-181-4 · Cited by 6
Long, D. R., Holmes, E. A., Lo, H.-Y., Penewit, K. M., Almazan, J. D., Hodgson, T., Berger, N. F., Bishop, Z. H., Lewis, J. D., Waalkes, A., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012394 · Cited by 5
Altwiley, D. A., Brignoli, T., Duggan, S., & Massey, R. C. (2023) · Microbiology · doi:10.1099/mic.0.001277 · Cited by 7
Bollar, G. E., Shaffer, K. M., Keith, J. D., Oden, A. M., Dowell, A. E., Ryan, K. J., Acosta, E. P., Guimbellot, J. S., Kiedrowski, M. R., & Birket, S. E. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae185 · Cited by 4
Cook, P., & Siraj, D. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00109-1 · Cited by 4
Herrin, B. E., Islam, S., Rentschler, K. N., Pert, L. H., Kopanski, S. P., & Wakeman, C. A. (2021) · Microbiology · doi:10.1099/mic.0.001044 · Cited by 4
“aureus in many ways mimics some of the phenotypic characteristics of persister cells, such as slow growth and resistance to antibiotics, and both states are naturally occurring [4, 25, 32, 34, 35].”
BackgroundSimple sequence repeats power Staphylococcus aureus adaptationPreprint
Guérillot, R., Hayes, A. S., Hachani, A., Giulieri, S. G., Donovan, L., Judd, L. M., Sharkey, L. K. R., da Silva, A. G., Seemann, T., Stinear, T. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.08.663602 · Cited by 3
Fuertes, C., Gonzalez, J. E., Suesca, E., Guzmán-Sastoque, P., Muñoz-Camargo, C., Manrique-Moreno, M., Carazzone, C., & Leidy, C. (2026) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2026.184552 · Cited by 3
Lee, J. D., Carda‐Diéguez, M., Vreugde, S., Cooksley, C. M., Mashayamombe, M., Dawson, J. A., Fitridge, R., Mira, Á., Zilm, P. S., & Kidd, S. P. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106918 · Cited by 2
Wilkinson, A. J. (2016) · ERA · Cited by 3
Vulpis, T. D., York, J. T., Clay, A. P., Polaske, T. J., Markovich, S. W., Lee, K., Chang, D. H., Palecek, S. P., Lynn, D. M., Sauer, J., et al. (2026) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6c00432 · Cited by 1
Evolutionary dynamics under phenotypic uncertaintyPreprint
Mohanty, V., Sappington, A., Shakhnovich, E. I., & Berger, B. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.15.711953 · Cited by 1
“In doing so, we introduce the first SDE that captures the nonlinear interactions of selection, mutation, and phenotypic uncertainty, which broadly encompasses phenotypic plasticity 30,32,33,39,49 , phenotypic noise 24,32,50–53 , and stochastic phenotype switching (SPS) 20,22,25,54 .”
Intracellular staphylococcus aureus in chronic rhinosinusitis.
Tan, N. C. (2013) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Importance of metabolic adaptations in intracellular persistence of Staphylococcus aureus
Tan, X. (2019) · theses.fr (ABES) · doi:10.70675/6e47b811z5956z4198zadf0zab83e2a3e90f
Bumann, D. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734161570.793566049
Effect of nanoscale zero valent iron toward bacteria and their response
Kotchaplai, P. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1567
Audoux, E. (2021) · theses.fr (ABES) · doi:10.70675/8bc7a837z4313z4b81z9bbfz5f6ef007443c · Cited by 1
Colonization and Persistence Strategies of Staphylococcus aureus
Becker, K. (2024) · Springer eBooks · doi:10.1007/978-981-99-9428-1_1
Tieu, E., Griebel, B. T., Carroll, B., Eydinova, A., & Ma, S. (2024) · Springer eBooks · doi:10.1007/978-3-031-65986-7_3
Xu, L., & Kidd, S. P. (2025) · Discover Bacteria. · doi:10.1007/s44351-025-00019-5
“The outcome is that there are cells being able to evade the immune response and to tolerate antimicrobials that would clear actively growing cells in the populations [4, 5].”
Ga-PpIX-Mediated Photodynamic Inactivation of Staphylococcus aureus Small-Colony Variants
Sivasubramaniam, B. P., & Wei, A. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00738
O’Brien, K., Miller, J. J., Johnson, R. J., Hoops, G. C., & John, A. R. O. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.26.714663
Etude de l'impact d'antibiotiques sur des biofilms de Staphylococcus aureus.
Marquès, C. (2016) · theses.fr (ABES) · doi:10.70675/818147f2z53fbz44a8za2fez0d9f10597bed
Riffaud, C. (2019) · theses.fr (ABES) · doi:10.70675/96c9ff69zc5b6z487cz96afz0191edf32242 · Cited by 1
Mortality Rate and Associated Factors Among Patients with Septic Arthritis at Pranangklao Hospital
Bunyod, A. (2026) · Journal of Medicine and Health Sciences · doi:10.14456/jmhs.2026.7
Metadata
- Authors
- Edwards, A. M.
- Affiliations
- Imperial College London (GB)
- Corresponding author
- Edwards, Andrew M.
- ORCID
- Edwards, Andrew M.
- Venue
- Journal of Bacteriology
- Publisher
- American Society for Microbiology
- Published
- 2012-10
- Volume
- 194
- Issue
- 19
- Pages
- 5404-5412
- ISSN
- 0021-9193 (ISSN-L)
- 1098-5530
- PMC
- PMC3457229
- OpenAlex
- W2083492619
- Cited by
- 83
- References
- 41
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 8 · 2023: 5 · 2022: 8 · 2021: 4 · 2020: 6 · 2019: 10 · 2018: 4 · 2017: 5 · 2016: 8 · 2015: 6 · 2014: 6 · 2013: 5
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Bacteriology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Imperial College London
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- Staphylococcus aureus, small colony variants, phenotypic switching, bacterial replication, antibiotic resistance, gentamicin resistance, bacterial persistence, bidirectional switching, bacterial life cycle
- MeSH terms
- Adaptation, Physiological, Anti-Bacterial Agents, Bacteriological Techniques, Cell Division, Gentamicins, Humans, Microbial Sensitivity Tests, Phenotype, Selection, Genetic, Staphylococcal Infections, Staphylococcus aureus, Drug Resistance, Bacterial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.